Audiogene, the first clinical trial in France for a gene therapy to treat hearing loss in children
From Institut Pasteur 04/02/24 The aim of this clinical trial, which has just received approval in France, is to assess the safety and efficacy of a new gene therapy drug in children aged between 6 and 31 months with profound hearing loss. Audiogene was developed by a French consortium composed of teams from the Hearing […]